We offer training opportunities for clinical and non-clinical students. Below are all the projects that are or were supported by the Centre with a non-clinical or intercalated studentship or a clinical research fellowship (including studentships from the former Imperial Centre) 

• Discovering, developing, and delivering, novel therapeutic strategies for MEK/ERK/RSK activated lethal prostate cancer - Dr Navita Somaiah (Division of Radiotherapy & Imaging, The ICR), Professor Trevor Graham (Division of Molecular Pathology, The ICR), Professor Alan Melcher (Division of Radiotherapy & Imaging, The ICR), Dr Anita Grigoriadis (Division of Breast Cancer Research, The ICR), Dr Tom Lund (Division of Molecular Pathology, The ICR), Dr Luis Zapata Ortiz (Division of Molecular Pathology, The ICR)

• Understanding the impact of radiotherapy on the nodal immune microenvironment and cross-talk with the primary tumour in breast cancer - Dr Adam Sharp (Division of Clinical Studies, The ICR), Professor Udai Banerji (Division of Cancer Therapeutics, The ICR), Professor Johann De Bono (Division of Clinical Studies, The ICR), Dr Jon Welti (Division of Clinical Studies, The ICR), Dr Marco Bezzi (Division of Molecular Pathology, The ICR), Dr Juan Jimenez Vacas (Division of Clinical Studies, The ICR)

• Novel liquid biopsies to guide treatment in recurrent/metastatic head and neck cancer - Dr Ben O'Leary (Division of Radiotherapy & Imaging, The ICR), Professor Jyoti Choudhary (Division of Cancer Biology, The ICR), and Dr Annie Baker (Division of Molecular Pathology, The ICR)

• Immune derived volatile biomarkers in oesophagogastric cancer - Professor Jessica Strid (Department of Immunology and Inflammation, Imperial College London), Professor George Hanna (Department of Surgery & Cancer, Imperial College London) and Dr Sam Au (Department of Bioengineering, Imperial College London)

• Developing transcription inhibitors as a new class of cancer therapeutics - Professor Simak Ali (Department of Surgery & Cancer, Imperial College London) and Professor Laki Buluwela (Department of Surgery & Cancer, Imperial College London)

Non Clinical Studentships

• Resolving the isoform-specific signalling of RSK1 and RSK4 in non-small cell lung cancer through combined artificial intelligence and molecular biology - Dr Olivier Pardo, Dr Kirill Veselkov and Professor Michael Seckl (Imperial, Surgery and Cancer) & Dr Paul Huang (ICR, Molecular Pathology).

   

• Fluorescent nanoparticle arrays for label-free monitoring of immunotherapy for bladder cancer - Professor Molly Stevens (Imperial, Materials) & Dr Anna Wilkins (ICR, Radiotherapy & Imaging)

   

• Novel p21-disrupting peptides to prevent quiescence and resistance to chemotherapy - Dr Anna Barnard (Imperial, Chemistry), Dr Alexis Barr (MRC-LMS, Institute of Clinical Sciences) & Dr Basil Greber (ICR, Structural Biology)

MB-PhD Studentships

• Cellular precision head and neck surgery by combination of microrobotics and molecular feedback - Dr Burak Temelkuran & Professor Vinidh Paleri

• Understanding the role of zinc in breast cancer progression by combining analytical chemistry and multi-omics techniques - Professor Mark Rehkamper, Dr Maggie Cheang & Dr Rebekah Moore

• Improving Targeted Drug Delivery to Tumours using Ultrasound and Acoustic Cluster Therapy: An Organ-in-Chip Approach - Professor Darryl Overby, Professor Jeffrey Bamber, Dr Emma Harris

Non Clinical Studentships

• Development of novel dual-target agents to treat neuroblastoma that combine selective protein degradation with synergistic inhibition - Professor Louis Chesler (ICR, Clinical Studies), Professor Matt Fuchter (Imperial, Chemistry), Professor Hector Keun & Dr Anke Nijhuis (Imperial, Surgery & Cancer) 

   

• An explant-in-chip platform to study immune-cancer cell interactions and enhance tumour immunogenicity ex vivo: A focus on radiotherapy - Professor Darryl Overby (Imperial, Bioengineering) & Professor Alan Melcher (ICR, Radiotherapy & Imaging)

   

• Unravelling the role of cancer associated fibroblasts in cancer evolution and drug resistance using microfluidics - Dr Sam Au (Imperial, Bioengineering) & Professor Udai Banerji (ICR, Cancer Therapeutics)

   

• Winners versus Losers: Deciphering the mechanism of cell competition via optogenetics and single cell tracking of organoids - Professor Pascal Meier (ICR, Breast Cancer Research), Dr Periklis Pantazis & Dr Chris Rowlands (Imperial, Bioengineering)

• Organ-on-chip platforms for investigating the influence of extracellular matrix components on tumour cell invasion from patient-derived lung explants - Dr Sam Au (Imperial, Bioengineering) & Dr Paul Huang (ICR, Molecular Pathology).

• Engineering next generation laminin targeted cancer immunotherapy - Dr Paul Huang (ICR, Molecular Pathology) & Dr Jun Ishihara (Imperial, Bioengineering)

• Accelerating volumetric MR Imaging for Real-Time Adaptive Radiotherapy - Dr Andreas Wetscherek (ICR, Radiotherapy & Imaging) & Professor Wayne Luk (Imperial, Computing).

• Spatial and temporal high resolution quantitative live imaging techniques to determine mechanisms of chromosomal instability and drug resistance in breast cancer patient-derived organoids - Professor Jorge Bernardino de la Serna (Imperial, National Heart & Lung Institute) & Professor Andrew Tutt (ICR, Breast Cancer Research)

• A Point-of-Care Diagnostic Device for Early Oncogene Detection in Cancer - Dr Ali Yetisen (Imperial, Chemical Engineering) & Professor Louis Chesler (ICR, Clinical Studies)

• Improving endometrial cancer diagnosis via detection of microRNA biomarkers from liquid biopsies: From biomarker discovery to screening test engineering - Dr Sylvain Ladame (Imperial, Bioengineering) & Professor Sadaf Ghaem-Maghami (Imperial, Surgery & Cancer)

• Bioengineering tumor-targeted cytokines or chemotherapy for effective, specific and personalised immunotherapy combinations in pancreatic cancer - Dr Anguraj Sadanandam (ICR, Molecular Pathology) & Dr Jun Ishihara (Imperial, Bioengineering)

• Bioharmonophores: Redefining Photodynamic Therapy of Cancer - Dr Periklis Pantazis and Dr Victoria Salem (Imperial, Bioengineering),  & Mr Christopher Peters (Imperial, Surgery & Cancer)

   

• Metabolic changes in. brain tumours: Development of novel therapies - Dr Elizabeth Want and Professor Tim Ebbels (Imperial, Metabolism, Digestion and Reproduction) & Dr Nelofer Syed  (Imperial, Brain Sciences).

• Super-resolution imaging to assess epigenetic evolution in ovarian high-grade serous carcinoma - Professor Iain McNeish (Imperial, Surgery & Cancer), Professor Paul French (Imperial, Physics) & Professor Chris Dunsby (Imperial, Physics)

• Developing a point-of-care diagnostic technology for ovarian cancer detection - Mr Srdjan Sasso (Imperial, Department of Metabolism, Digestion and Reproduction) & Professor Molly Stevens (Imperial, Materials).

• Exploring PARP biology and therapy response via metabolic flux analysis and a novel chemical proteomics workflow - Professor Hector Keun (Imperial, Surgery & Cancer) , Professor Ed Tate & Dr Adrian Benito Mauricio (Imperial, Chemistry).

• Hyperspectral Circumferential Resection Margin Assessment for Gastrointestinal Cancer Surgery - Professor Dan Elson & Mr Christopher Peters (Imperial, Surgery & Cancer)